NCT05521997 - Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

March 7, 2032

Study Completion Date

March 7, 2032

Conditions

Advanced Cervical CarcinomaCervical CancerCervix CancerCancer of the Cervix

Interventions

DRUG

Telaglenastat

-800 mg twice per day by mouth

RADIATION

Radiation treatment

"* Standard of care~* External beam radiation therapy delivered daily 4 days a week and 1 day per week of brachytherapy."

DRUG

Cisplatin

"* Standard of care~* Weekly administration of cisplain"

Trial Locations (1)

Washington University School of Medicine, St Louis